Skip navigation
  • Sciety Labs đź§Ş (Experimental)
  • Search
Sciety application utilities

Infectious Diseases (except HIV/AIDS)

  • Subscribe to feed (RSS)

Showing page 399 of 716 pages of list content

  • Cold plasma for SARS-CoV-2 Inactivation

    This article's authors
    1. Zhitong Chen
    2. Gustavo Garcia
    3. Vaithilingaraja Arumugaswami
    4. Richard E. Wirz
    This article has 1 evaluations Latest evaluation on Mar 1, 2021 Published on Sep 23, 2020
  • Mobilefuge: A low-cost, portable, open source, 3D-printed centrifuge that can be used for purification of saliva samples for SARS-CoV2 detection

    This article's authors
    1. Mohini Bhupathi
    2. Ganga Chinna Rao Devarapu
    This article has 1 evaluations Latest evaluation on Jan 8, 2021 Published on Jan 8, 2021
  • The Accuracy of Healthcare Worker versus Self Collected (2-in-1) Oropharyngeal and Bilateral Mid-Turbinate (OPMT) Swabs and Saliva Samples for SARS-CoV-2

    This article's authors
    1. Seow Yen Tan
    2. Hong Liang Tey
    3. Ernest Tian Hong Lim
    4. Song Tar Toh
    5. Yiong Huak Chan
    6. Pei Ting Tan
    7. Sing Ai Lee
    8. Cheryl Xiaotong Tan
    9. Gerald Choon Huat Koh
    10. Thean Yen Tan
    11. Chuin Siau
    This article has 1 evaluations Latest evaluation on Mar 1, 2021 Published on Sep 18, 2020
  • Temporal and Spatial Heterogeneity of Host Response to SARS-CoV-2 Pulmonary Infection

    This article's authors
    1. Niyati Desai
    2. Azfar Neyaz
    3. Annamaria Szabolcs
    4. Angela R. Shih
    5. Jonathan H. Chen
    6. Vishal Thapar
    7. Linda T. Nieman
    8. Alexander Solovyov
    9. Arnav Mehta
    10. David J. Lieb
    11. Anupriya S. Kulkarni
    12. Christopher Jaicks
    13. Christopher J. Pinto
    14. Dejan Juric
    15. Ivan Chebib
    16. Robert B. Colvin
    17. Arthur Y. Kim
    18. Robert Monroe
    19. Sarah E Warren
    20. Patrick Danaher
    21. Jason W Reeves
    22. Jingjing Gong
    23. Erroll H Rueckert
    24. Benjamin D. Greenbaum
    25. Nir Hacohen
    26. Stephen M. Lagana
    27. Miguel N. Rivera
    28. Lynette M. Sholl
    29. James R. Stone
    30. David T. Ting
    31. Vikram Deshpande
    This article has 1 evaluations Latest evaluation on Mar 1, 2021 Published on Aug 2, 2020
  • Tocilizumab in nonventilated patients hospitalized with Covid-19 pneumonia

    This article's authors
    1. Carlos Salama
    2. Jian Han
    3. Linda Yau
    4. William G. Reiss
    5. Benjamin Kramer
    6. Jeffrey D. Neidhart
    7. Gerard J. Criner
    8. Emma Kaplan-Lewis
    9. Rachel Baden
    10. Lavannya Pandit
    11. Miriam L. Cameron
    12. Julia Garcia-Diaz
    13. Victoria Chávez
    14. Martha Mekebeb-Reuter
    15. Ferdinando Lima Menezes
    16. Reena Shah
    17. Maria F. González-Lara
    18. Beverly Assman
    19. Jamie Freedman
    20. Shalini V. Mohan
    This article has 1 evaluations Latest evaluation on Oct 26, 2020 Published on Oct 23, 2020
  • If long-term suppression is not possible, how do we minimize mortality for COVID-19 and other emerging infectious disease outbreaks?

    This article's authors
    1. Andreas Handel
    2. Joel C. Miller
    3. Yang Ge
    4. Isaac Chun-Hai Fung
    This article has 1 evaluations Latest evaluation on Mar 1, 2021 Published on Apr 3, 2020
  • Impact of non-pharmaceutical interventions against COVID-19 in Europe: A quasi-experimental study

    This article's authors
    1. Paul R Hunter
    2. Felipe J Colón-González
    3. Julii Brainard
    4. Steven Rushton
    This article has 2 evaluations Latest evaluation on Mar 1, 2021 Published on Jul 17, 2020
  • Emergence of Novel SARS-CoV-2 Variants in the Netherlands

    This article's authors
    1. Aysun Urhan
    2. Thomas Abeel
    This article has 1 evaluations Latest evaluation on Nov 5, 2020 Published on Nov 4, 2020
  • Dynamics and future of SARS-CoV-2 in the human host

    This article's authors
    1. Michael Gillman
    2. Nuno Crokidakis
    This article has 1 evaluations Latest evaluation on Mar 1, 2021 Published on Jul 27, 2020
  • Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of New York City Metro Blood Donors using Multiple SARS-CoV-2 Serological Assays: Implications for Controlling the Epidemic and “Reopening”

    This article's authors
    1. Daniel K. Jin
    2. Daniel. J. Nesbitt
    3. Jenny Yang
    4. Haidee Chen
    5. Julie Horowitz
    6. Marcus Jones
    7. Rianna Vandergaast
    8. Timothy Carey
    9. Samantha Reiter
    10. Stephen J Russell
    11. Christos Kyratsous
    12. Andrea Hooper
    13. Jennifer Hamilton
    14. Manuel Ferreira
    15. Sarah Deng
    16. Donna Straus
    17. Aris Baras
    18. Christopher D. Hillyer
    19. Larry L. Luchsinger
    This article has 1 evaluations Latest evaluation on Nov 9, 2020 Published on Nov 7, 2020
Previous Next
Stay updated. Get involved.
Subscribe to Mailing List
  • Blog
  • About Sciety
  • Contact
  • Follow us on Twitter
  • Follow us on Facebook
© 2022 eLife Sciences Publications Ltd. Legal information